U.S. Gastroenterology Ambulatory Surgery Centers Market (By Ownership: Hospital-affiliated, Freestanding, Corporation-owned) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

U.S. Gastroenterology Ambulatory Surgery Centers Market Size and Growth 2024 to 2033

The U.S. gastroenterology ambulatory surgery centers market size was estimated at around USD 6.19 billion in 2023 and it is projected to hit around USD 11.97 billion by 2033, growing at a CAGR of 6.82% from 2024 to 2033. The U.S. Gastroenterology Ambulatory Surgery Centers (ASCs) market is a vital segment of the healthcare industry, offering specialized, outpatient surgical services for a range of gastrointestinal (GI) conditions. As healthcare moves toward cost-effective and patient-centered care, ASCs are becoming an increasingly preferred option over traditional hospital settings for certain procedures.

U.S. Gastroenterology Ambulatory Surgery Centers Market Size 2024 to 2033

Key Pointers

  • The U.S. Gastroenterology Ambulatory Surgery Centers (ASC) Market.
  • By Ownership, the freestanding ownership model generated the maximum market share of 61% in 2023.
  • By Ownership, the corporation-owned centers are anticipated to grow at the noteworthy CAGR of 5.43% from 2024 to 2033.

What are the Growth Factors of U.S. Gastroenterology Ambulatory Surgery Centers Market?

The growth of the U.S. gastroenterology ambulatory surgery centers (ASCs) market is primarily driven by the rising prevalence of gastrointestinal disorders such as colorectal cancer, inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD). As the population ages, the demand for gastrointestinal procedures has increased, fueling the expansion of ASCs as cost-effective alternatives to hospitals. Additionally, advancements in minimally invasive surgical techniques and diagnostic tools have made outpatient surgeries more feasible, reducing patient recovery times and healthcare costs. Furthermore, the shift toward value-based care, coupled with favorable reimbursement policies from private and public payers, is encouraging more healthcare providers to adopt the ASC model, further bolstering the market's growth.

What are the Trends in U.S. Gastroenterology Ambulatory Surgery Centers Market?

  • Shift Toward Outpatient Care: The healthcare industry is moving toward outpatient settings due to their cost-effectiveness and convenience. Gastroenterology ASCs provide same-day surgeries and quicker recovery times, which are highly appealing to patients and payers alike.
  • Advancements in Minimally Invasive Procedures: Technological improvements, such as enhanced endoscopic techniques, have led to safer, minimally invasive gastrointestinal surgeries. These advancements allow procedures to be conducted more efficiently, driving the adoption of ASCs.
  • Rising Prevalence of GI Disorders: Conditions like colorectal cancer, Crohn’s disease, and IBS are becoming more common, especially among the aging U.S. population. The growing number of patients requiring diagnostic and surgical GI procedures is a significant driver for the expansion of gastroenterology ASCs.
  • Cost-Effectiveness Over Hospitals: ASCs offer a more affordable option for patients compared to traditional hospitals. With lower facility fees and reduced overhead costs, ASCs are becoming the preferred choice for both patients and healthcare providers seeking cost savings without compromising care quality.

What are the Key Challenges Faced by U.S. Gastroenterology Ambulatory Surgery Centers Market?

  • Reimbursement Pressure: Although ASCs benefit from favorable reimbursement policies, constant changes in Medicare and private payer reimbursement rates create uncertainty. Any reductions or delays in payments can affect the profitability of ASCs, making it challenging to maintain financial stability.
  • High Initial Investment Costs: Establishing an ASC requires substantial capital investment in specialized medical equipment, facility construction, and hiring experienced staff. For new market entrants or smaller gastroenterology practices, these costs can be prohibitive.
  • Competition with Hospitals and Other ASCs: Gastroenterology ASCs face growing competition from hospital outpatient departments (HOPDs) and other ASCs. Hospitals often have more extensive resources and infrastructure, making it difficult for independent ASCs to attract patients, especially in highly competitive regions.
  • Staffing Shortages: The healthcare industry, including gastroenterology ASCs, is facing a shortage of skilled healthcare professionals, such as nurses and anesthesiologists. Recruiting and retaining qualified staff is becoming increasingly difficult, leading to operational challenges and potential delays in patient care.

Ownership Insights

The freestanding ownership model dominates the market, accounting for the largest revenue share at 61%. This segment is largely comprised of physician-owned ambulatory surgery centers. The professional control over clinical operations and the quality of care provided by physicians significantly contributes to the market's growth. Freestanding centers allow physicians to focus on a select number of procedures in a dedicated setting. Furthermore, endoscopic ambulatory surgery centers, which are freestanding, offer gastrointestinal procedures at a lower cost compared to expensive hospital-based alternatives. These factors have driven the high demand for freestanding centers among patients and encouraged companies to adopt various strategies to capitalize on market growth.

Corporation-owned centers are projected to grow at a CAGR of 5.43% in the coming years. This growth is fueled by the increasing collaboration between corporations and physicians to establish joint ventures. Established companies in the healthcare sector bring expertise in financial management, operations, and recruitment of top talent, making these collaborations attractive. As more partnerships between corporations and physicians continue, this ownership model in the ambulatory surgery center market is expected to expand, with key players focusing on enhancing efficiency and outcomes.

Country Insights

The U.S. Gastroenterology Ambulatory Surgery Centers (ASC) Market is experiencing significant growth due to the increasing number of ASCs across the country. One of the main drivers is the high cost associated with traditional healthcare services, which often include unnecessary hospitalization expenses. ASCs offer a cost-effective alternative by providing surgeries with greater efficiency and at lower costs, which has made them a preferred option for many patients. This shift in patient preference has encouraged many hospitals to adopt the ASC model to streamline surgeries.

Many large hospitals and ASCs are expanding their presence in the U.S., further strengthening the market. The country boasts a well-established network of ambulatory surgery centers, which contributes to continuous market growth. Additionally, healthcare companies are innovating to meet the rising demand for specialized gastroenterology services in outpatient settings. This ongoing innovation and expansion ensure that the market for gastroenterology ASCs in the U.S. will continue to grow.

Who are the Top Manufactures in U.S. Gastroenterology Ambulatory Surgery Centers Market?

  • TH Medical.
  • GE Healthcare
  • Universal Health Services, Inc.
  • Covenant Physician Partners
  • Regent Surgical
  • Cardinal Health.
  • Boston Scientific Corporation
  • Olympus Corporation
  • Koninklijke Philips N.V.
  • Cook Medical

Recent Developments

  • In May 2024, Koninklijke Philips, a leading player in health technology, entered into a long-term strategic partnership with Radboud University Medical Center. This collaboration aims to provide the hospital with the latest monitoring applications, enhancing patient care. Additionally, both parties have signed a service agreement to ensure ongoing clinical and technical support for the maintenance of monitoring systems and the IT platform. This partnership is expected to improve clinical outcomes by minimizing unnecessary alerts, allowing seamless data access, and enabling clinical decision-making from any location.
  • In July 2024, GE HealthCare signed a strategic agreement with Amazon Web Services (AWS) to develop foundational models with specific functions and generative artificial intelligence (AI) applications. This collaboration will accelerate the delivery of innovative solutions aimed at improving patient outcomes, enhancing diagnostic and screening accuracy, and promoting equitable care. Additionally, these advancements are designed to streamline healthcare access and reduce the workload on healthcare providers, helping to create a more efficient healthcare ecosystem.Top of Form

Bottom of Form

U.S. Gastroenterology Ambulatory Surgery Centers Market Segmentation:

By Ownership

  • Hospital-affiliated
  • Freestanding
  • Corporation-owned
  • Others

Frequently Asked Questions

The U.S. gastroenterology ambulatory surgery centers market size was reached at USD 6.19 billion in 2023 and it is projected to hit around USD 11.97 billion by 2033.

The U.S. gastroenterology ambulatory surgery centers market is growing at a compound annual growth rate (CAGR) of 6.82% from 2024 to 2033.

Key factors that are driving the U.S. gastroenterology ambulatory surgery centers market growth include rising need for solutions to reduce healthcare costs, increasing focus on patient-centric care, and strong government support.

The leading companies operating in the U.S. gastroenterology ambulatory surgery centers market are TH Medical.; GE Healthcare; Universal Health Services, Inc.; Covenant Physician Partners; Regent Surgical; Cardinal Health.; Boston Scientific Corporation; Olympus Corporation; Koninklijke Philips NV and Cook Medical.

Chapter 1. Introduction

1.1. Research Objective                    

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Gastroenterology Ambulatory Surgery Centers Market

5.1. COVID-19 Landscape: U.S. Gastroenterology Ambulatory Surgery Centers Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Gastroenterology Ambulatory Surgery Centers Market, By Ownership

8.1.U.S. Gastroenterology Ambulatory Surgery Centers Market, by Ownership Type, 2024-2033

8.1.1. Hospital-affiliated

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Freestanding

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Corporation-owned

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. U.S. Gastroenterology Ambulatory Surgery Centers Market, Regional Estimates and Trend Forecast

9.1. U.S.

9.1.1. Market Revenue and Forecast, by Ownership (2021-2033)

Chapter 10. Company Profiles

10.1. Abbot

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Abbot

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Abbot

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Abbot

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Abbot

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Abbot

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Abbot

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Abbot

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3.Financial Performance

10.8.4. Recent Initiatives

10.9. Abbot

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Abbot

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers